Fmoc-D-glutamic acid γ-benzyl ester is a protected D-glutamate derivative in which the α-amino group is masked by an Fmoc carbamate and the γ-carboxyl group is esterified as a benzyl ester, while the α-carboxyl group remains available as a free acid for coupling chemistry. The molecule contains a glutamate backbone with a side-chain containing an additional carboxyl functionality, and the stereochemistry is specified as D at the α-carbon; the benzyl ester and Fmoc group act as protecting groups that control chemoselectivity by reducing undesired reactions at the γ-carboxyl and α-amino sites, respectively. In peptide synthesis workflows, this protected amino acid is used as a building block to introduce a glutamate side chain bearing a removable γ-carboxyl protecting group, supporting stepwise assembly and subsequent functionalization of the γ-carboxyl during peptide or peptide-conjugate preparation.
CAT No: CP00731
CAS No:104091-11-4
Synonyms/Alias:Fmoc-D-Glu(OBzl)-OH;104091-11-4;Fmoc-D-Glu(Bzl)-OH;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(benzyloxy)-5-oxopentanoicacid;AmbotzFAA1485;CTK8E9859;MolPort-005-942-154;ZINC2564719;0956AA;Fmoc-L-glutamicacid|Abenzylester;AJ-41044;AK-49219;AN-32723;SC-09501;RT-012938;J-300099;Q-101686;(2R)-5-benzyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-pentanoicacid
Fmoc-D-glutamic acid γ-benzyl ester is an Fmoc-protected D-glutamate derivative in which the α-amino group is masked by the fluorenylmethoxycarbonyl (Fmoc) protecting group and the α-carboxyl functionality is present as a γ-benzyl ester. The molecule therefore combines a chiral amino-acid backbone with an esterified side chain that is stable under many peptide-coupling conditions yet can be selectively transformed for downstream functionalization. The γ-benzyl ester provides a robust, hydrophobic handle for protecting-group strategy during solid-phase or solution-phase peptide synthesis, while the Fmoc carbamate enables base-mediated deprotection to reveal the free amine for sequential coupling. The stereochemical D-configuration at the glutamate center supports incorporation of non-proteinogenic or stereochemically defined residues in peptide scaffolds, and the presence of a single protected side-chain ester helps tune reactivity toward amide formation, ester cleavage, and subsequent derivatization chemistry.
1. Peptide Synthesis
Fmoc-D-glutamic acid γ-benzyl ester is applied in peptide building workflows where Fmoc-based amino acid chemistry governs stepwise chain elongation. The Fmoc-protected α-amine participates in standard peptide coupling after orthogonal deprotection, while the γ-benzyl ester protects the glutamate side chain from premature acylation or side reactions during assembly. The glutamate backbone geometry and D-stereochemistry enable incorporation of stereodefined glutamate residues into peptide sequences, including peptide analogs designed for altered conformational preferences or protease resistance. Downstream, the benzyl ester can be converted to the corresponding free acid or used as a controlled precursor for side-chain functionalization, supporting iterative peptide analog construction and library synthesis. The compound thus functions as a protected amino acid intermediate tailored for peptide coupling chemistry and subsequent glutamate side-chain elaboration.
2. Side-Chain Functionalization
Fmoc-D-glutamic acid γ-benzyl ester is used for side-chain modification strategies that require an orthogonally protected glutamate ester during synthetic planning. The γ-benzyl ester enables selective transformations after peptide assembly or during fragment synthesis, allowing controlled conversion to carboxylic acid derivatives that can be reactivated for amide coupling, activated ester formation, or further derivatization. The Fmoc group provides a temporary protection element for the α-amine, supporting chemoselective side-chain chemistry without interference from free amine reactivity. The D-configuration can be leveraged to generate stereochemically defined glutamate analogs for structure-activity relationship studies and chemical biology probes where stereochemistry impacts binding and recognition. The resulting functionalized glutamate derivatives serve as intermediates for peptidomimetics, linker-bearing scaffolds, and other amino acid-derived constructs.
3. Peptidomimetics And SAR Studies
Fmoc-D-glutamic acid γ-benzyl ester is employed in peptidomimetic and SAR-oriented synthesis where stereodefined glutamate residues are incorporated to modulate electrostatics, hydrogen-bonding patterns, and conformational behavior. The protected α-amine and protected γ-ester allow systematic construction of analog series using consistent coupling and deprotection logic, while the D-stereochemistry introduces non-native chirality that can alter target interactions. The γ-carboxyl equivalent, masked as a benzyl ester, can be maintained during scaffold assembly and later converted to functional acid forms for consistent presentation of side-chain charge or for attachment of additional moieties. The Fmoc strategy also supports rapid generation of peptide-like fragments and constrained analogs that can be used to map structure-function relationships. The compound therefore acts as a stereochemically controlled amino acid intermediate for SAR studies and peptidomimetic scaffold refinement.
4. Bioconjugation Linkers
Fmoc-D-glutamic acid γ-benzyl ester is suitable for bioconjugation chemistry where glutamate-derived linkers require orthogonal protection to manage multi-step coupling sequences. The γ-benzyl ester can serve as a protected carboxyl handle that can be unveiled when conjugation-ready functionality is required, enabling subsequent formation of amide bonds to lysine-like nucleophiles, hydrazide/semicarbazide linkages, or other carboxyl-reactive conjugation motifs. The Fmoc group supports controlled release of the α-amine for incorporation into peptide-based targeting ligands or for constructing conjugates that include defined stereochemistry. The D-glutamate configuration can influence linker conformation and local rigidity, which may be relevant when designing conjugates for controlled recognition in chemical biology workflows. The compound thereby provides a protected glutamate platform for downstream conjugate assembly and linker-mediated molecular modification.
5. Pharmaceutical Intermediate Preparation
Fmoc-D-glutamic acid γ-benzyl ester is used as a process-relevant intermediate in fine chemical and pharmaceutical manufacturing contexts that require protected amino acid building blocks for controlled derivatization. The Fmoc carbamate and benzyl ester protecting-group set supports manufacturing-compatible handling by separating the timing of amine exposure from carboxyl-side-chain activation, which can be important for minimizing undesired side reactions during multi-step synthesis. The chiral D-glutamate core provides stereochemical fidelity for downstream intermediates used in peptide-derived active ingredient candidates, prodrug-like constructs, or stereochemically defined intermediates for analytical method development. The benzyl ester protection can be leveraged to generate glutamate acid derivatives on demand for subsequent coupling steps, while the Fmoc group enables reliable orthogonal deprotection logic within synthetic routes. The compound thus aligns with amino acid derivative manufacturing needs where protected functionality management and stereochemical control are central to robust intermediate preparation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.